My HPRA: Register

NASONEX

50 Mcg/Dose Nasal Spray Suspension

PCO ManufacturingPPA0465/146/001

Main Information

Trade NameNASONEX
Active SubstancesMOMETASONE FUROATE
Strength50 Mcg/Dose
Dosage FormNasal Spray Suspension
Licence HolderPCO Manufacturing
Licence NumberPPA0465/146/001

Group Information

ATC CodeR01AD09 corticosteroids

Status

Authorised/WithdrawnAuthorised
Licence Issued19/08/2005
Supply StatusSupply through pharmacies only
Dispensing StatusProduct subject to prescription which may not be renewed (A)
Marketing Status--Unknown--
Promotion StatusPromotion to Healthcare Professionals only
Conditions of Licence

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print

Summary of Product Characteristics

View More SPC Headings

Latest Changes to Medicine Info & SPC

View all available

Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.